Partner David Rosen was quoted in an article published in Business Insider on April 18, 2014, titled “Why America Needs This Dangerous New Painkiller.” The article discusses Zohydro, a new hydrocodone painkiller, and the sharp criticism it has drawn because of the potential for abuse since it does not yet have tamper-resistant technology that would make it more difficult to crush and snort. Rosen was quoted saying, “”With respect to having a product available for use for chronic pain, when the drug is used appropriately, yes, this is a good call.”
People
Related News
July 24, 2026
In the News
Laura Ganoza Featured in Law360 Spotlight – 'You Learn Something New in Every Case'
Foley & Lardner LLP partner Laura Ganoza discusses her career path and IP practice in Law360's “She Has a Point” series.
July 24, 2026
In the News
Cathryn Regulski Featured Across Media Following Foley Arrival
Foley & Lardner LLP partner Cathryn Regulski is spotlighted across media for her recent arrival to the firm's Washington, D.C. office.
July 22, 2026
In the News
Louis Lehot Shares Insights on AI Startup Acqui-Hiring
Foley & Lardner LLP partner Louis Lehot discusses the evolving landscape of acqui-hire transactions in the Law.com article, “What an Acqui-Hire Looks Like for an AI Startup Today.”